Liao Z, Li J, Zhao Y, Wang Z, Wang X, Qiu D
World J Urol. 2024; 42(1):10.
PMID: 38183428
DOI: 10.1007/s00345-023-04708-1.
Rebaine Y, Nasser M, Girerd B, Leroux C, Cottin V
Eur Respir Rev. 2021; 30(161).
PMID: 34348978
PMC: 9488995.
DOI: 10.1183/16000617.0348-2020.
Peng J, Tu H, Hong C
Orphanet J Rare Dis. 2021; 16(1):335.
PMID: 34344419
PMC: 8330058.
DOI: 10.1186/s13023-021-01974-3.
Kingswood J, Belousova E, Benedik M, Carter T, Cottin V, Curatolo P
Front Neurol. 2020; 11:972.
PMID: 33041968
PMC: 7526256.
DOI: 10.3389/fneur.2020.00972.
Chu W, Chiang L, Chan D, Wong W, Chan G
Orphanet J Rare Dis. 2020; 15(1):264.
PMID: 32988393
PMC: 7523393.
DOI: 10.1186/s13023-020-01517-2.
Natural history of a fibrous cephalic plaque and sustained eight decade follow-up in an 80 year old with tuberous sclerosis complex type 2.
Kirk C, Donnelly D, Hardy R, Shepherd C, Morrison P
Ulster Med J. 2020; 89(1):14-16.
PMID: 32218621
PMC: 7027183.
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).
Zollner J, Franz D, Hertzberg C, Nabbout R, Rosenow F, Sauter M
Orphanet J Rare Dis. 2020; 15(1):23.
PMID: 31964424
PMC: 6975094.
DOI: 10.1186/s13023-019-1258-3.
Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.
Jansen A, Belousova E, Benedik M, Carter T, Cottin V, Curatolo P
Front Neurol. 2019; 10:705.
PMID: 31333563
PMC: 6616060.
DOI: 10.3389/fneur.2019.00705.
Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness.
Kingswood J, Belousova E, Benedik M, Carter T, Cottin V, Curatolo P
Nephrol Dial Transplant. 2018; 34(3):502-508.
PMID: 29697822
PMC: 6399480.
DOI: 10.1093/ndt/gfy063.
The Risks of Renal Angiomyolipoma: Reviewing the Evidence.
Seyam R, Alkhudair W, Kattan S, Alotaibi M, Alzahrani H, Altaweel W
J Kidney Cancer VHL. 2017; 4(4):13-25.
PMID: 29090118
PMC: 5644357.
DOI: 10.15586/jkcvhl.2017.97.
Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.
Rovira A, Ruiz-Falco M, Garcia-Esparza E, Lopez-Laso E, Macaya A, Malaga I
J Neurooncol. 2014; 118(2):205-223.
PMID: 24771286
DOI: 10.1007/s11060-014-1429-y.
Subependymal giant cell astrocytoma: current concepts, management, and future directions.
Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y
Childs Nerv Syst. 2014; 30(4):561-70.
PMID: 24549759
DOI: 10.1007/s00381-014-2383-x.
Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.
Wu W, Kirov I, Tal A, Babb J, Milla S, Oved J
Epilepsy Behav. 2013; 27(2):319-25.
PMID: 23524469
PMC: 3644963.
DOI: 10.1016/j.yebeh.2013.02.018.
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.
Moavero R, Pinci M, Bombardieri R, Curatolo P
Childs Nerv Syst. 2011; 27(8):1203-10.
PMID: 21305305
DOI: 10.1007/s00381-011-1406-0.
The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis.
Jiang T, Jia G, Ma Z, Luo S, Zhang Y
Childs Nerv Syst. 2010; 27(1):55-62.
PMID: 20422196
DOI: 10.1007/s00381-010-1159-1.
Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.
Yeung R, Katsetos C, Klein-Szanto A
Am J Pathol. 1997; 151(5):1477-86.
PMID: 9358774
PMC: 1858083.
